Disease Info Card

Nodular Regenerative Hyperplasia

Information about Nodular Regenerative Hyperplasia: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Nodular Regenerative Hyperplasia

Most recent studies have shown that Nodular Regenerative Hyperplasia shares some biological mechanisms with adenoma, carcinoma, fibrosis, focal-nodular-hyperplasia, focal-nodular-hyperplasia-of-the-liver, hemangioma, hemorrhage, hepatocellular-adenoma, hyperplasia, hypertension-portal, hypertensive-disease, liver-carcinoma, liver-cirrhosis, liver-diseases, liver-neoplasms, liver-regeneration-disorder, malignant-neoplasms, malignant-paraganglionic-neoplasm, neoplasm-metastasis, neoplasms.

Among the many pathways, these few ones have gauged particular interests from scientists studying Nodular Regenerative Hyperplasia, and have been seen in publications frequently: Aging, Aldosterone Secretion, Angiogenesis, Cell Adhesion, Cell Cycle, Cell Growth, Cell Proliferation, Circadian Rhythm, Coagulation, Cortisol Secretion, Enucleation, Excretion, Hypersensitivity, Localization, Methylation, Pathogenesis, Pigmentation, Regeneration, Secretion, Transport

Quite a number of genes have been found to play important roles in Nodular Regenerative Hyperplasia, such as AFP, AR, CASR, CD34, FAM126A, FUT2, GGT1, GLUL, GPC3, KLK3, KRT19, KRT7, PCNA, POMC, PRL, PTH, PTRH1, REN, SQLE, TP53. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.